搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 18 小時前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
Thursday's analyst calls: Discount retailers upgraded, more good news for Carvana, tough ...
CNBC· 18 小時前... JPMorgan upgraded shares following best-ever earnings results Wednesday and indicated the ...
Morning Bid: Fed QT taper calms the horses, yen pops again
Reuters· 18 小時前Anxious bond traders seem to have taken solace from the Federal Reserve's surprisingly ...
Japan's May 1 intervention may have cost $23.6 bln, BOJ data shows
Reuters· 19 小時前Japanese officials may have spent some 3.66 trillion yen ($23.59 billion) on Wednesday in the ...
Dabur India beats Q4 profit view on steady domestic demand, lower costs
Reuters· 19 小時前Consumer goods maker Dabur India reported a bigger-than-expected 16.2% rise in fourth-quarter profit on Thursday, boosted ...
CCTV Digital Script 29/04/24
CNBC· 19 小時前Over the past two years, inflation has increasingly widened the gap between the average American and the "American Dream ...
Soccer star's murder highlights South Africa's crime problem as election nears
Reuters· 19 小時前In the South African township where Luke Fleurs grew up, some friends joined gangs before they ...
South Korea raises diplomatic alert levels citing North Korea threats
Reuters· 19 小時前The five locations include Seoul's embassies in Cambodia, Laos and Vietnam, as well as ...
Bearish bets on most Asian FX climb to multi-month highs
Reuters· 20 小時前Short bets on most Asian currencies firmed to touch multi-month highs as growing expectations of U.S. interest rates staying ...
Chicago Fire vs New England Revolution Prediction: Expect nothing new from New England
telecomasia.net· 20 小時前Chicago Fire and New England Revolution have been two underperforming teams in the league or at ...